LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
3.190
-0.110 (-3.33%)
At close: Oct 20, 2026, 4:00 PM EDT
3.200
+0.010 (0.31%)
Pre-market: Oct 21, 2026, 5:19 AM EDT
LENZ Therapeutics Market Cap
LENZ Therapeutics has a market cap or net worth of $100.23 million as of October 20, 2026. It is the 25,201st most valuable company in the world and the 4,098th biggest in the United States. Its market cap has decreased by 90.22% in one year.
Market Cap
100.23M
Enterprise Value
-119.20M
1-Year Change
-90.22%
Global Rank
Country Rank
#4,098 United States
Category
ChartMarket Cap Chart
Since March 22, 2024, LENZ Therapeutics's market cap has decreased from $413.64M to $100.23M, a decrease of -75.77%. That is a compound annual growth rate of -42.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2026 | 100.23M | -79.98% |
| Dec 31, 2025 | 500.64M | -36.94% |
| Dec 31, 2024 | 793.95M | 91.94% |
| Mar 22, 2024 | 413.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kazia Therapeutics | 107.57M |
| Tevogen | 106.54M |
| enGene Therapeutics | 105.89M |
| Black Diamond Therapeutics | 103.99M |
| Inovio Pharmaceuticals | 103.40M |
| Vivani Medical | 101.03M |
| Cibus | 100.12M |
| PolyPid | 99.12M |